[Skip to Content]
Claim CME
Infectious Diseases

High vs Low Dose Chloroquine Diphosphate For COVID-19

Educational Objective
To understand the risks of high dose Chloroquine Diphosphate
0.25 Credit CME
JAMA Network Open
April 28, 2020 Video 14 min 40 sec

MOC/CME Information

Watch Claim CME

Steven M. Bradley, MD, MPH joins JAMA Network editors to discuss a randomized clinical trial evaluating the safety and efficacy of 2 chloroquine diphosphate dosages in patients with severe coronavirus disease 2019 (COVID-19). JNOLive is a weekly broadcast featuring conversations about the latest research being published in JAMA Network Open. Follow JAMA Network Open on Facebook, Twitter and YouTube.

Sign in to take quiz and track your certificates

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

Related Articles

  1. Effect of High vs Lose Dosage of Chloroquine Diphosphate on SARS-CoV-2 Infection
    1.00 CME

  2. Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019
    1.00 CME

See More About

Critical Care Medicine Clinical Pharmacy and Pharmacology Infectious Diseases Adverse Drug Events Pharmacy and Clinical Pharmacology Coronavirus (COVID-19)
Close
Close
Close

Name Your Search

Save Search
Privacy Policy|Terms of Use
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close
Close
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue